Pharmazeutische Zeitung online
Stellungnahme

Klinisch relevante Interaktion zwischen Clopidogrel und Protonenpumpen-Inhibitoren

09.04.2009
Datenschutz bei der PZ

Literatur

<typolist type="1">

Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009;180(7):699-700

Ho PM, Maddox TM, Wang L, et al. Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome. JAMA 2009;301:937-944.

Klotz U. Das Interaktionspotential der Protonenpumeninhibitoren. Verdauungskrankheiten 2002;20:26-31.

Dunn SP, Macaulay TE, Brennan DM, et al. Baseline Proton Pump Inhibitor (PPI) Use is Associated with Increased Cardiovascular Events with and without the Use of Clopidogrel in the CREDO Trial. Circulation 2008;118:815.

Simon T, Verstuyft C, Mary-Krause M, et al. Genetic Determinants of Response to Clopidogrel and Cardiovascular Events. 2009;360:363-375.

Trenk D, Hochholzer W, Fromm MF, et al. Cytochrome P450 C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 2008;51:1925-34.

Mega JL, Close SL, Wiviott SD, et al. Cytochrome P-450 Polymorphisms and Response to Clopidogrel. 2009;360:354-362.

Collet JP, Hulot JS, Pena A, et al. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 2009;373:309-17.

Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J 2009;157:148 e1-5.

Sibbing D, Morath T, Braun S, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thrombosis and Haemostasis 2009;101:epub.

Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol 2008;51:256-60.

Small DS, Farid NA, Payne CD, et al. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol 2008;48:475-84.

Li X-Q, Andersson TB, Ahlstrom M, Weidolf L. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazol, esomeprazol, lansoprazol, pantoprazol, and rabeprazol on human cytochrome P450 activities. 2004;32:821-827.

 

Mehr von Avoxa